“For the most part, if you’re the CEO of a beer company or a spirits company right now, it’s a terrible time, because in your shareholder meetings they’re saying, ‘What’s our cannabis strategy?’ And, for the most part, the big companies are saying, ‘Well, we have a group that’s making a strategy for a strategy,”
Canopy Growth CEO Bruce Linton in a TV interview with Bloomberg.
This Trend is Undeniable… It’s Happening Now!
From Colorado to the streets of Las Vegas and all throughout Canada, alcohol sales are falling as consumers now have a better alternative:
legal cannabis.
DUIs, spousal abuse, and many other negative effects from alcohol are falling as well.
Don’t get me wrong, I enjoy alcohol like many of our readers, and I regularly consume a nice full glass or two of red wine during the evening hours.
However, there is no denying that cannabis is a very real alternative (or even an enhancer) to alcohol.
Molson Coors, who has seen declining sales in its home state of Colorado, is said to be in talks with several Canadian-based cannabis companies to invest in and collaborate with for future cannabis-infused beverages.
A recent report revealed that a major announcement could soon be made, as Coors has been in very close talks with at least four separate cannabis companies.
Constellation Brands and Southern Glazer’s Wine & Spirits have both made recent announcements of additional investments into the cannabis space.
The Future Money Trends letter is focused on cannabis-related investments and will report on new investment opportunities here in 2018, but the one I have to bring to your attention now is directly involved in cannabis-infused drinks.
A massive shift is underway in the global beverage industry. Consumers are turning away from sugary sodas and energy drinks and turning to healthier alternatives.
I believe this will also include cannabis, which is a trend we definitely want to be invested in.
Our current stock recommendation is already a fast-growing player in the healthier alternative drink market, and with their major announcement recently, they’ll also be one of the first to introduce a cannabis-infused beverage.
Koios Beverage Corp. (CSE: KBEV & US: KBEVF) is a newly-listed company that is trading on the Canadian Stock Exchange.
When I spoke with a high-level scientist in the beverage industry, I was basically told that the clinical trials this company is currently running could make this an imminent takeover target because health is the largest trend in the sector, by far.
This is a completely undiscovered beverage play that we believe could soon become wildly popular with investors as they roll out their cannabis-infused drinks with the creation of Cannavated Beverages Co., a wholly-owned subsidiary of Koios.
The core branded drinks for Koios have nootropics, which are cognitive enhancers, natural extracts that improve memory functions, creativity, and motivation.
North America is, by far, the largest consumer of nootropics, and the growth projections are stunning.
Not surprising are the sales of Coca-Cola, who’s seeing a decline in their most popular caffeinated sugar drinks.
*Koios is currently available in over 2,000 retail locations, so the upside here is perhaps greater than any company we’ve ever profiled.
It’s also potentially a future takeover for a giant, like a Molson Coors, Anheuser Busch, PepsiCo, Constellation Brands, or Coca-Cola.
Legalization is here and higher tax revenues, new jobs, and lower crime are happening all throughout North America.
Consider buying shares of Koios Beverages (CSE: KBEV & US: KBEVF).
Best Regards,
Daniel Ameduri
President, FutureMoneyTrends.com